CYNTHIA SACHAROK: Open Payments
NPI 1558413492 · MILMONT PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 92 payments from 25 companies in 2025. Trend: 2023 $2,872 · 2024 $2,979 · 2025 $2,031
Food & beverage: $2,031
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $326 |
| Novo Nordisk Inc | 12 | $228 |
| ABBVIE INC. | 11 | $169 |
| Amgen Inc. | 10 | $142 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $118 |
| Astellas Pharma US Inc | 5 | $117 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
Products named: BREZTRI, VRAYLAR, AIRSUPRA, Symbravo, Kerendia, Veozah, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across PA — which companies pay providers there.
